Guohai Innovation Capital Investment Management
Shenzhen, Guangdongghcxzb.com
Overview
A private equity firm and the fund management subsidiary of Guohai Securities (000750). It serves as the platform for first-level market equity investments, focusing on sectors including TMT, healthcare, energy conservation, and advanced manufacturing. As of the end of 2024, its cumulative assets under management exceeded 20.8 billion RMB.
Portfolio Companies
11
Website
ghcxzb.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Bivision Biomedical Technology (Nanjing) Co., Ltd. | May 2026 | Series B | Co-investor |
| Bivision Biomedical Technology (Nanjing) Co., Ltd. | May 2026 | Series B | Co-investor |
| Shanghai Leekr Technology Co.,Ltd. | Jun 2024 | Series C | Co-investor |
| Guangdong Guna Technology Co. Ltd. | Oct 2023 | Series A | Co-investor |
| Muniu Technology | Feb 2023 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
